Our US Pharmaceuticals portfolio includes key marketed products, many of which are leaders in their respective therapeutic areas. Since 2000, our US division has received the most approvals of any pharmaceutical company in the industry.
Key pharmaceutical products marketed by Novartis in the US are listed below by therapeutic area, brand name and generic name.
Important Information:
Disease categories and product names are listed for your convenience in searching for and finding information about Novartis offerings. They are not intended to provide complete medical or product information. SHOULD YOU HAVE A MEDICAL CONDITION, PROMPTLY SEE YOUR OWN MEDICAL DOCTOR OR HEALTHCARE PROVIDER. Please see important safety information in the complete Prescribing Information, available by clicking on highlighted links near product names.
by generic name
acetylcholine chloride
aldesleukin
aliskiren
patient prescribing information
aliskiren and hydrochlorothiazide
patient prescribing information
aliskiren and valsartan, USP
patient prescribing information
amlodipine and valsartan
patient prescribing information
amlodipine besylate and benazepril hydrochloride combination capsule
patient prescribing information
amlodipine, valsartan, hydrochlorothiozide
patient prescribing information
artemether/lumefantrine
basiliximab
benazepril hydrochloride
benazepril hydrochloride and hydrochlorothiazide USP
bromocriptine mesylate
calcitonin-salmon ( nasal spray )
patient prescribing information
calcitonin-salmon ( for injection )
canakinumab
patient prescribing information
carbamazepine ( chewable tablets and suspension )
carbamazepine ( extended-release tablets )
carbidopa, levodopa and entacapone
clozapine
cyclosporine ( oral solution, USP )
cyclosporine ( injection )
cyclosporine ( soft gelatin capsule, USP )
cyclosporine capsules, USP
cyclosporine oral solution, USP
darifenacin
patient prescribing information
deferasirox
deferoxamine mesylate
dexmethylphenidate hydrochloride ( extended-release capsules )
dexmethylphenidate hydrochloride ( tablets )
diclofenac potassium
diclofenac sodium ( ophthalmic solution 0.1% )
diclofenac sodium ( extended-release tablets )
diclofenac sodium ( enteric-coated tablets )
entacapone
estradiol ( transdermal system )
estradiol ( transdermal system )
estradiol ( transdermal system )
patient prescribing information
estradiol/norethindrone acetate
everolimus
famciclovir
fluvastatin sodium ( capsules )
fluvastatin sodium ( extended-release tablets )
patient prescribing information
imatinib mesylate
interferon beta-1b
letrozole
methylergonovine maleate ( capsules )
methylergonovine maleate ( injection, USP )
methylergonovine maleate ( tablets, USP )
methylphenidate hydrochloride ( tablets, USP )
methylphenidate hydrochloride ( sustained-release tablets, USP )
methylphenidate hydrochloride ( extended-release capsules )
metoprolol tartrate
metoprolol tartrate USP and hydrochlorothiazide USP
mycophenolic acid
nateglinide
nilotinib
octreotide acetate ( injection )
octreotide acetate ( for injectable suspension )
omalizumab
oxcarbazepine
pamidronate disodium
pimecrolimus
patient prescribing information
rivastigmine
patient prescribing information
rivastigmine tartrate
telbivudine
terbinafine hydrochloride ( oral granules )
terbinafine hydrochloride ( tablets )
tobramycin
patient prescribing information
valsartan
patient prescribing information
valsartan and hydrochlorothiazide
patient prescribing information
verteporfin
zoledronic acid ( Injection )
patient prescribing information
zoledronic acid ( for injection )
DISEASES & CONDITIONS
Knowing more about different diseases and conditions makes it easier for you to take a more active role in keeping you and your family healthy.
ACCESS TO MEDICINES
Novartis puts patients first. We want to create value for all patients, including those who cannot afford treatment. That is why we established Patient Assistance Now, a resource that allows you to access programs that may help you pay for your Novartis medicines.
PATIENT ASSISTANCE PROGRAMS
Through our Patient Assistance Programs, we are committed to providing access to our medications for those most in need.